Colgm I have ta agree. But I would disagree with your grade for management, especially their communication with shareholders.
The product has promise. But the market looks like they have moved on from Oncosil. This story has been going for way too long. The market has moved on and away from Oncosil. It’s almost a corpse or a shell.
Thus is unfortunate especially for long suffering shareholders. Terrible outcome. Trading at 12 cents?? Pathetic return. Management grade D minus. And I’m being generous. Very very poor. And the market tends to agree.
Product has potential but with the current Board the market has given the big finger!
Colgm I have ta agree. But I would disagree with your grade for...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $114.3K | 13.41M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 9972750 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 22973299 | 19 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |